Major Efficacy of Trabectedin in 2 Metastatic Osteosarcoma Patients with Wild-Type Asp1104 ERCC5 Tumor Status - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Onkologie Year : 2013

Major Efficacy of Trabectedin in 2 Metastatic Osteosarcoma Patients with Wild-Type Asp1104 ERCC5 Tumor Status

Domains

Life Sciences [q-bio]

Philippe Pourquier  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-02438834

Submitted on : Tuesday, January 14, 2020-1:29:30 PM

Last modification on : Saturday, June 25, 2022-11:42:01 PM

Not file

Dates and versions

inserm-02438834 , version 1 (14-01-2020)

Identifiers

Cite

Lauris Gastaud, Esma Saada-Bouzid, Valérie Le Morvan, Philippe Pourquier, Antoine Ianessi, et al.. Major Efficacy of Trabectedin in 2 Metastatic Osteosarcoma Patients with Wild-Type Asp1104 ERCC5 Tumor Status. Onkologie, 2013, 36 (11), pp.2-2. ⟨10.1159/000355664⟩. ⟨inserm-02438834⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM COMUE-NORMANDIE UNIV-COTEDAZUR
35 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More